ALZHEIMER DEMENTIA
Clinical trials for ALZHEIMER DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DEMENTIA trials appear
Sign up with your email to follow new studies for ALZHEIMER DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a brain scan predict who benefits from Alzheimer's antibody drugs?
Disease control Not yet recruitingThis study tests whether monoclonal antibody drugs can slow Alzheimer's disease progression in 120 people with mild cognitive impairment or mild Alzheimer's. Researchers will use PET scans to measure brain proteins and see which patients benefit most. The goal is to better target…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Could a lower dose of Alzheimer's drug be just as effective?
Disease control Not yet recruitingThis study looks at whether a lower dose of the medication lecanemab can control Alzheimer's disease as well as the standard dose. Researchers will compare brain scans, thinking tests, and blood markers in 140 people with early-stage Alzheimer's over 18 months. The goal is to fin…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC